Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1267

1.

SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI.

Battaglini M, Jenkinson M, De Stefano N; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2017 Dec 8. doi: 10.1002/hbm.23828. [Epub ahead of print]

PMID:
29222814
2.

Patterns of progressive atrophy vary with age in Alzheimer's disease patients.

Fiford CM, Ridgway GR, Cash DM, Modat M, Nicholas J, Manning EN, Malone IB, Biessels GJ, Ourselin S, Carmichael OT, Cardoso MJ, Barnes J; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2017 Nov 14;63:22-32. doi: 10.1016/j.neurobiolaging.2017.11.002. [Epub ahead of print]

3.

A spatio-temporal reference model of the aging brain.

Huizinga W, Poot DHJ, Vernooij MW, Roshchupkin GV, Bron EE, Ikram MA, Rueckert D, Niessen WJ, Klein S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2017 Dec 1. pii: S1053-8119(17)30867-4. doi: 10.1016/j.neuroimage.2017.10.040. [Epub ahead of print]

4.

Probability of Alzheimer's disease in breast cancer survivors based on gray-matter structural network efficiency.

Kesler SR, Rao V, Ray WJ, Rao A; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement (Amst). 2017 Nov 1;9:67-75. doi: 10.1016/j.dadm.2017.10.002. eCollection 2017.

5.

Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset.

Meijerman A, Amiri H, Steenwijk MD, Jonker MA, van Schijndel RA, Cover KS, Vrenken H; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2017 Nov 30. doi: 10.3174/ajnr.A5459. [Epub ahead of print]

PMID:
29191870
6.

APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease.

Hohman TJ, Dumitrescu L, Oksol A, Wagener M, Gifford KA, Jefferson AL; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2017 Nov 30;12(11):e0188501. doi: 10.1371/journal.pone.0188501. eCollection 2017.

7.

Longitudinal Functional Brain Mapping in Supernormals.

Wang X, Ren P, Baran TM, Raizada RDS, Mapstone M, Lin F; Alzheimer’s Disease Neuroimaging Initiative.

Cereb Cortex. 2017 Nov 23:1-11. doi: 10.1093/cercor/bhx322. [Epub ahead of print]

PMID:
29186360
8.

Validation of T1w-based segmentations of white matter hyperintensity volumes in large-scale datasets of aging.

Dadar M, Maranzano J, Ducharme S, Carmichael OT, Decarli C, Collins DL; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2017 Nov 27. doi: 10.1002/hbm.23894. [Epub ahead of print]

PMID:
29181872
9.

Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression.

Bartels C, Wagner M, Wolfsgruber S, Ehrenreich H, Schneider A; Alzheimer’s Disease Neuroimaging Initiative.

Am J Psychiatry. 2017 Nov 28:appiajp201717040404. doi: 10.1176/appi.ajp.2017.17040404. [Epub ahead of print]

PMID:
29179578
10.

Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.

Tan CH, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Dillon WP, Bonham LW, Yokoyama JS, Karch CM, Brewer JB, Rabinovici GD, Miller BL, Schellenberg GD, Kauppi K, Feldman HA, Holland D, McEvoy LK, Hyman BT, Bennett DA, Andreassen OA, Dale AM, Desikan RS; Alzheimer’s Disease Neuroimaging Initiative.

Acta Neuropathol. 2017 Nov 24. doi: 10.1007/s00401-017-1789-4. [Epub ahead of print]

PMID:
29177679
11.

Evaluation of Alzheimer's disease progression based on clinical dementia rating scale with missing responses and covariates.

Das K, Rana S, Roy S; , and for the Alzheimer’s Disease Neuroimaging Initiative.

J Biopharm Stat. 2017 Nov 27:1-16. doi: 10.1080/10543406.2017.1402780. [Epub ahead of print]

PMID:
29173033
12.

Bayesian latent time joint mixed effect models for multicohort longitudinal data.

Li D, Iddi S, Thompson WK, Donohue MC; Alzheimer’s Disease Neuroimaging Initiative.

Stat Methods Med Res. 2017 Jan 1:962280217737566. doi: 10.1177/0962280217737566. [Epub ahead of print]

PMID:
29168432
13.

Data-Driven Sequence of Changes to Anatomical Brain Connectivity in Sporadic Alzheimer's Disease.

Oxtoby NP, Garbarino S, Firth NC, Warren JD, Schott JM, Alexander DC; Alzheimer’s Disease Neuroimaging Initiative.

Front Neurol. 2017 Nov 7;8:580. doi: 10.3389/fneur.2017.00580. eCollection 2017.

14.

Brain medical image diagnosis based on corners with importance-values.

Gao L, Pan H, Li Q, Xie X, Zhang Z, Han J, Zhai X; Alzheimer’s Disease Neuroimaging Initiative.

BMC Bioinformatics. 2017 Nov 21;18(1):505. doi: 10.1186/s12859-017-1903-6.

15.

Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.

Moreno-Grau S, Rodríguez-Gómez O, Sanabria Á, Pérez-Cordón A, Sánchez-Ruiz D, Abdelnour C, Valero S, Hernández I, Rosende-Roca M, Mauleón A, Vargas L, Lafuente A, Gil S, Santos-Santos MÁ, Alegret M, Espinosa A, Ortega G, Guitart M, Gailhajanet A, de Rojas I, Sotolongo-Grau Ó, Ruiz S, Aguilera N, Papasey J, Martín E, Peleja E; Alzheimer's Disease Neuroimaging Initiative, Lomeña F, Campos F, Vivas A, Gómez-Chiari M, Tejero MÁ, Giménez J, Serrano-Ríos M, Orellana A, Tárraga L, Ruiz A, Boada M; FACEHBI study group.

Alzheimers Dement. 2017 Nov 20. pii: S1552-5260(17)33794-9. doi: 10.1016/j.jalz.2017.10.005. [Epub ahead of print]

16.

Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.

Lange C, Suppa P, Pietrzyk U, Makowski MR, Spies L, Peters O, Buchert R; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2018;61(1):373-388. doi: 10.3233/JAD-170705.

PMID:
29154285
17.

Fluid biomarker agreement and interrelation in dementia due to Alzheimer's disease.

Alexopoulos P, Roesler J, Werle L, Thierjung N, Lentzari I, Ortner M, Grimmer T, Laskaris N, Politis A, Gourzis P, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

J Neural Transm (Vienna). 2017 Nov 15. doi: 10.1007/s00702-017-1810-z. [Epub ahead of print]

PMID:
29143217
18.

Amyloid Network Topology Characterizes the Progression of Alzheimer's Disease During the Predementia Stages.

Pereira JB, Strandberg TO, Palmqvist S, Volpe G, van Westen D, Westman E, Hansson O; Alzheimer’s Disease Neuroimaging Initiative.

Cereb Cortex. 2017 Nov 9:1-10. doi: 10.1093/cercor/bhx294. [Epub ahead of print]

PMID:
29136123
19.

Multivariate regression analysis of structural MRI connectivity matrices in Alzheimer's disease.

Rasero J, Amoroso N, La Rocca M, Tangaro S, Bellotti R, Stramaglia S; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2017 Nov 14;12(11):e0187281. doi: 10.1371/journal.pone.0187281. eCollection 2017.

20.

A variant in PPP4R3A protects against alzheimer-related metabolic decline.

Christopher L, Napolioni V, Khan RR, Han SS, Greicius MD; Alzheimer's Disease Neuroimaging Initiative.

Ann Neurol. 2017 Nov 11. doi: 10.1002/ana.25094. [Epub ahead of print]

PMID:
29130521

Supplemental Content

Loading ...
Support Center